enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Titan Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Titan_Pharmaceuticals

    Titan's principal asset is Probuphine, [5] [6] a slow-release implant formulation of buprenorphine [7] for the treatment of opioid addiction or chronic pain. FDA Approval was granted on 26 May 2016. [8] It was licensed to Braeburn Pharmaceuticals for marketing and commercialization. [6]

  3. Endo International - Wikipedia

    en.wikipedia.org/wiki/Endo_International

    Endo is one of the companies named in lawsuits by the states of Ohio, [42] Missouri and Mississippi [43] as responsible for the US opioid epidemic. Its 10-K statement indicates that a majority of the company's US revenue in 2016 was derived from the sale of prescription pain killers, predominantly opioids. [44]

  4. Fentanyl - Wikipedia

    en.wikipedia.org/wiki/Fentanyl

    Fentanyl is a highly potent synthetic piperidine opioid primarily used as an analgesic.It is 30 to 50 times more potent than heroin and 100 times more potent than morphine; [10] its primary clinical utility is in pain management for cancer patients and those recovering from painful surgeries.

  5. Comptroller announces launch of Naloxone Distribution Grant ...

    www.aol.com/news/comptroller-announces-launch...

    Apr. 11—AUSTIN — Texas Comptroller Glenn Hegar announced Thursday that the Opioid Abatement Fund Council's (OAFC or the Council) Naloxone Distribution Grant Opportunity is open for applications.

  6. McKinsey & Company agrees to pay $650M for helping ... - AOL

    www.aol.com/mckinsey-company-agrees-pay-650...

    McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive ...

  7. Consulting giant McKinsey to pay $650M to settle DOJ ... - AOL

    www.aol.com/news/consulting-giant-mckinsey-pay...

    McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to ...

  8. Alkermes plc - Wikipedia

    en.wikipedia.org/wiki/Alkermes_plc

    Alkermes has four proprietary commercial drug products [5] approved for the treatment of schizophrenia, bipolar I disorder, alcohol dependence and opioid dependence.These include olanzapine and samidorphan (Lybalvi), an atypical antipsychotic and opioid modulator combination intended for the treatment of schizophrenia and bipolar I disorder; aripiprazole lauroxil (Aristada), a long-acting ...

  9. Consulting firm McKinsey to pay $650 million to resolve US ...

    www.aol.com/news/consulting-firm-mckinsey-pay...

    BOSTON (Reuters) -McKinsey & Co has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm's work advising opioid manufacturer OxyContin maker ...